Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study.

Pulvirenti A, Margonis GA, Morales-Oyarvide V, McIntyre CA, Lawrence SA, Goldman DA, Gonen M, Weiss MJ, Ferrone CR, He J, Brennan MF, Cameron JL, Lillemoe KD, Kingham TP, Balachandran V, Qadan M, D'Angelica MI, Jarnagin WR, Wolfgang CL, Castillo CF, Allen PJ.

Ann Surg. 2019 Dec 5. doi: 10.1097/SLA.0000000000003703. [Epub ahead of print]

PMID:
31804389
2.

Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer.

Babic A, Rosenthal MH, Bamlet WR, Takahashi N, Sugimoto M, Danai LV, Morales-Oyarvide V, Khalaf N, Dunne RF, Brais LK, Welch MW, Zellers CL, Dennis C, Rifai N, Prado CM, Caan B, Sundaresan TK, Meyerhardt JA, Kulke MH, Clish CB, Ng K, Heiden MGV, Petersen GM, Wolpin BM.

Cancer Epidemiol Biomarkers Prev. 2019 Dec;28(12):2062-2069. doi: 10.1158/1055-9965.EPI-19-0370. Epub 2019 Sep 18.

PMID:
31533940
3.

Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival.

Hamada T, Yuan C, Bao Y, Zhang M, Khalaf N, Babic A, Morales-Oyarvide V, Cochrane BB, Gaziano JM, Giovannucci EL, Kraft P, Manson JE, Ng K, Nowak JA, Rohan TE, Sesso HD, Stampfer MJ, Amundadottir LT, Fuchs CS, De Vivo I, Ogino S, Wolpin BM.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1868-1875. doi: 10.1158/1055-9965.EPI-19-0577. Epub 2019 Aug 19.

PMID:
31427306
4.

Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.

Das KK, Geng X, Brown JW, Morales-Oyarvide V, Huynh T, Pergolini I, Pitman MB, Ferrone C, Al Efishat M, Haviland D, Thompson E, Wolfgang C, Lennon AM, Allen P, Lillemoe KD, Fields RC, Hawkins WG, Liu J, Castillo CF, Das KM, Mino-Kenudson M.

Gastroenterology. 2019 Sep;157(3):720-730.e2. doi: 10.1053/j.gastro.2019.05.014. Epub 2019 Jun 5.

PMID:
31175863
5.

Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk.

Hamada T, Yuan C, Yurgelun MB, Perez K, Khalaf N, Morales-Oyarvide V, Babic A, Nowak JA, Rubinson DA, Giannakis M, Ng K, Kraft P, Stampfer MJ, Giovannucci EL, Fuchs CS, Ogino S, Wolpin BM.

Br J Cancer. 2019 Apr;120(8):848-854. doi: 10.1038/s41416-019-0426-5. Epub 2019 Mar 14.

PMID:
30867564
6.

Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance).

Morales-Oyarvide V, Yuan C, Babic A, Zhang S, Niedzwiecki D, Brand-Miller JC, Sampson-Kent L, Ye X, Li Y, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Wu K, Willett WC, Giovannucci EL, Wolpin BM, Meyerhardt JA, Fuchs CS, Ng K.

J Natl Cancer Inst. 2019 Feb 1;111(2):170-179. doi: 10.1093/jnci/djy098.

7.

Incidence of Mismatch Repair Protein Deficiency and Associated Clinicopathologic Features in a Cohort of 104 Ovarian Endometrioid Carcinomas.

Bennett JA, Pesci A, Morales-Oyarvide V, Da Silva A, Nardi V, Oliva E.

Am J Surg Pathol. 2019 Feb;43(2):235-243. doi: 10.1097/PAS.0000000000001165.

PMID:
30256257
8.

Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance).

Guercio BJ, Zhang S, Niedzwiecki D, Li Y, Babic A, Morales-Oyarvide V, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Zoltick ES, Stampfer M, Ng K, Wu K, Willett WC, Giovannucci EL, Meyerhardt JA, Fuchs CS.

PLoS One. 2018 Jul 19;13(7):e0199244. doi: 10.1371/journal.pone.0199244. eCollection 2018.

9.

Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors.

Bennett JA, Braga AC, Pinto A, Van de Vijver K, Cornejo K, Pesci A, Zhang L, Morales-Oyarvide V, Kiyokawa T, Zannoni GF, Carlson J, Slavik T, Tornos C, Antonescu CR, Oliva E.

Am J Surg Pathol. 2018 Oct;42(10):1370-1383. doi: 10.1097/PAS.0000000000001119.

10.

Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.

Yurgelun MB, Chittenden AB, Morales-Oyarvide V, Rubinson DA, Dunne RF, Kozak MM, Qian ZR, Welch MW, Brais LK, Da Silva A, Bui JL, Yuan C, Li T, Li W, Masuda A, Gu M, Bullock AJ, Chang DT, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Thorner AR, Ducar MD, Wollison BM, Khalaf N, Perez K, Syngal S, Aguirre AJ, Hahn WC, Meyerson ML, Fuchs CS, Ogino S, Hornick JL, Hezel AF, Koong AC, Nowak JA, Wolpin BM.

Genet Med. 2019 Jan;21(1):213-223. doi: 10.1038/s41436-018-0009-5. Epub 2018 Jul 2.

11.

Plasma inflammatory cytokines and survival of pancreatic cancer patients.

Babic A, Schnure N, Neupane NP, Zaman MM, Rifai N, Welch MW, Brais LK, Rubinson DA, Morales-Oyarvide V, Yuan C, Zhang S, Poole EM, Wolpin BM, Kulke MH, Barbie DA, Wong K, Fuchs CS, Ng K.

Clin Transl Gastroenterol. 2018 Apr 25;9(4):145. doi: 10.1038/s41424-018-0008-5.

12.

Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer.

Hamada T, Khalaf N, Yuan C, Morales-Oyarvide V, Babic A, Nowak JA, Qian ZR, Ng K, Rubinson DA, Kraft P, Giovannucci EL, Stampfer MJ, Fuchs CS, Ogino S, Wolpin BM.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1300-1306.e3. doi: 10.1016/j.cgh.2018.02.022. Epub 2018 Feb 21. Erratum in: Clin Gastroenterol Hepatol. 2019 Apr;17(5):1008.

13.

Statin use and pancreatic cancer risk in two prospective cohort studies.

Hamada T, Khalaf N, Yuan C, Babic A, Morales-Oyarvide V, Qian ZR, Nowak JA, Ng K, Kraft P, Rubinson DA, Stampfer MJ, Giovannucci EL, Fuchs CS, Ogino S, Wolpin BM.

J Gastroenterol. 2018 Aug;53(8):959-966. doi: 10.1007/s00535-018-1430-x. Epub 2018 Jan 23.

PMID:
29362938
14.

Intraductal Papillary Mucinous Neoplasms of the Pancreas: Strategic Considerations.

Morales-Oyarvide V, Fong ZV, Fernández-Del Castillo C, Warshaw AL.

Visc Med. 2017 Dec;33(6):466-476. doi: 10.1159/000485014. Epub 2017 Dec 8.

15.

Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies.

Khalaf N, Yuan C, Hamada T, Cao Y, Babic A, Morales-Oyarvide V, Kraft P, Ng K, Giovannucci E, Ogino S, Stampfer M, Cochrane BB, Manson JE, Clish CB, Chan AT, Fuchs CS, Wolpin BM.

Gastroenterology. 2018 Apr;154(5):1380-1390.e5. doi: 10.1053/j.gastro.2017.12.001. Epub 2017 Dec 8. Erratum in: Gastroenterology. 2019 Mar;156(4):1223.

16.

Taking the measure of lung adenocarcinoma: towards a quantitative approach to tumor spread through air spaces (STAS).

Morales-Oyarvide V, Mino-Kenudson M.

J Thorac Dis. 2017 Sep;9(9):2756-2761. doi: 10.21037/jtd.2017.07.97. No abstract available.

17.

Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma.

Qian ZR, Rubinson DA, Nowak JA, Morales-Oyarvide V, Dunne RF, Kozak MM, Welch MW, Brais LK, Da Silva A, Li T, Li W, Masuda A, Yang J, Shi Y, Gu M, Masugi Y, Bui J, Zellers CL, Yuan C, Babic A, Khalaf N, Aguirre A, Ng K, Miksad RA, Bullock AJ, Chang DT, Tseng JF, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Thorner AR, Ducar M, Wollison B, Laing A, Hahn WC, Meyerson M, Fuchs CS, Ogino S, Hornick JL, Hezel AF, Koong AC, Wolpin BM.

JAMA Oncol. 2018 Mar 8;4(3):e173420. doi: 10.1001/jamaoncol.2017.3420. Epub 2018 Mar 8.

18.

Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes.

Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Warshaw AL, Lillemoe KD, Sahani DV, Pergolini I, Attiyeh MA, Al Efishat M, Rezaee N, Hruban RH, He J, Weiss MJ, Allen PJ, Wolfgang CL, Fernández-Del Castillo C.

J Gastrointest Surg. 2018 Feb;22(2):226-234. doi: 10.1007/s11605-017-3602-z. Epub 2017 Oct 18.

PMID:
29047068
19.

Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.

Morales-Oyarvide V, Rubinson DA, Dunne RF, Kozak MM, Bui JL, Yuan C, Qian ZR, Babic A, Da Silva A, Nowak JA, Khalaf N, Brais LK, Welch MW, Zellers CL, Ng K, Chang DT, Miksad RA, Bullock AJ, Tseng JF, Swanson RS, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Hornick JL, Ogino S, Fuchs CS, Hezel AF, Koong AC, Wolpin BM.

Br J Cancer. 2017 Dec 5;117(12):1874-1882. doi: 10.1038/bjc.2017.349. Epub 2017 Oct 5.

20.

Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma.

Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Sahani DV, Pergolini I, Negreros-Osuna AA, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C.

Pancreatology. 2017 Nov - Dec;17(6):920-926. doi: 10.1016/j.pan.2017.08.073. Epub 2017 Sep 8.

PMID:
28890154
21.

Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.

Pergolini I, Morales-Oyarvide V, Mino-Kenudson M, Honselmann KC, Rosenbaum MW, Nahar S, Kem M, Ferrone CR, Lillemoe KD, Bardeesy N, Ryan DP, Thayer SP, Warshaw AL, Fernández-Del Castillo C, Liss AS.

PLoS One. 2017 Aug 30;12(8):e0182855. doi: 10.1371/journal.pone.0182855. eCollection 2017.

22.

Influence of dietary insulin scores on survival in colorectal cancer patients.

Yuan C, Bao Y, Sato K, Nimptsch K, Song M, Brand-Miller JC, Morales-Oyarvide V, Zoltick ES, Keum N, Wolpin BM, Meyerhardt JA, Chan AT, Willett WC, Stampfer MJ, Wu K, Giovannucci EL, Fuchs CS, Ng K.

Br J Cancer. 2017 Sep 26;117(7):1079-1087. doi: 10.1038/bjc.2017.272. Epub 2017 Aug 17.

23.

Critical role for arginase 2 in obesity-associated pancreatic cancer.

Zaytouni T, Tsai PY, Hitchcock DS, DuBois CD, Freinkman E, Lin L, Morales-Oyarvide V, Lenehan PJ, Wolpin BM, Mino-Kenudson M, Torres EM, Stylopoulos N, Clish CB, Kalaany NY.

Nat Commun. 2017 Aug 14;8(1):242. doi: 10.1038/s41467-017-00331-y.

24.

Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.

Pergolini I, Sahora K, Ferrone CR, Morales-Oyarvide V, Wolpin BM, Mucci LA, Brugge WR, Mino-Kenudson M, Patino M, Sahani DV, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C.

Gastroenterology. 2017 Nov;153(5):1284-1294.e1. doi: 10.1053/j.gastro.2017.07.019. Epub 2017 Jul 21.

PMID:
28739282
25.

Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases.

Bennett JA, Weigelt B, Chiang S, Selenica P, Chen YB, Bialik A, Bi R, Schultheis AM, Lim RS, Ng CKY, Morales-Oyarvide V, Young RH, Reuter VE, Soslow RA, Oliva E.

Mod Pathol. 2017 Oct;30(10):1476-1488. doi: 10.1038/modpathol.2017.56. Epub 2017 Jun 30.

26.

Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum.

Bennett JA, Nardi V, Rouzbahman M, Morales-Oyarvide V, Nielsen GP, Oliva E.

Mod Pathol. 2017 Oct;30(10):1489-1503. doi: 10.1038/modpathol.2017.69. Epub 2017 Jun 30.

27.

Cigarette Smoking and Pancreatic Cancer Survival.

Yuan C, Morales-Oyarvide V, Babic A, Clish CB, Kraft P, Bao Y, Qian ZR, Rubinson DA, Ng K, Giovannucci EL, Ogino S, Stampfer MJ, Gaziano JM, Sesso HD, Cochrane BB, Manson JE, Fuchs CS, Wolpin BM.

J Clin Oncol. 2017 Jun 1;35(16):1822-1828. doi: 10.1200/JCO.2016.71.2026. Epub 2017 Mar 30.

28.

Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer.

Bao Y, Prescott J, Yuan C, Zhang M, Kraft P, Babic A, Morales-Oyarvide V, Qian ZR, Buring JE, Cochrane BB, Gaziano JM, Giovannucci EL, Manson JE, Ng K, Ogino S, Rohan TE, Sesso HD, Stampfer MJ, Fuchs CS, De Vivo I, Amundadottir LT, Wolpin BM.

Gut. 2017 Jun;66(6):1116-1122. doi: 10.1136/gutjnl-2016-312510. Epub 2016 Oct 21.

29.

Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms.

Babic A, Bao Y, Qian ZR, Yuan C, Giovannucci EL, Aschard H, Kraft P, Amundadottir LT, Stolzenberg-Solomon R, Morales-Oyarvide V, Ng K, Stampfer MJ, Ogino S, Buring JE, Sesso HD, Gaziano JM, Rifai N, Pollak MN, Anderson ML, Cochrane BB, Luo J, Manson JE, Fuchs CS, Wolpin BM.

Cancer Res. 2016 Dec 15;76(24):7160-7167. Epub 2016 Oct 25.

30.

Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment.

Huynh TG, Morales-Oyarvide V, Campo MJ, Gainor JF, Bozkurtlar E, Uruga H, Zhao L, Gomez-Caraballo M, Hata AN, Mark EJ, Lanuti M, Engelman JA, Mino-Kenudson M.

J Thorac Oncol. 2016 Nov;11(11):1869-1878. doi: 10.1016/j.jtho.2016.08.134. Epub 2016 Aug 24.

31.

Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.

Nishino M, Hoang MP, Della Pelle P, Morales-Oyarvide V, Huynh TG, Mark EJ, Mino-Kenudson M.

Cancer Cytopathol. 2016 Jul;124(7):472-84. doi: 10.1002/cncy.21707. Epub 2016 Feb 29.

32.

Vitamin D and Physical Activity in Patients With Colorectal Cancer: Epidemiological Evidence and Therapeutic Implications.

Morales-Oyarvide V, Meyerhardt JA, Ng K.

Cancer J. 2016 May-Jun;22(3):223-31. doi: 10.1097/PPO.0000000000000197. Review.

33.

Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival.

Yuan C, Qian ZR, Babic A, Morales-Oyarvide V, Rubinson DA, Kraft P, Ng K, Bao Y, Giovannucci EL, Ogino S, Stampfer MJ, Gaziano JM, Sesso HD, Buring JE, Cochrane BB, Chlebowski RT, Snetselaar LG, Manson JE, Fuchs CS, Wolpin BM.

J Clin Oncol. 2016 Aug 20;34(24):2899-905. doi: 10.1200/JCO.2015.66.3005. Epub 2016 Jun 20.

34.

PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes.

Rosenbaum MW, Bledsoe JR, Morales-Oyarvide V, Huynh TG, Mino-Kenudson M.

Mod Pathol. 2016 Sep;29(9):1104-12. doi: 10.1038/modpathol.2016.95. Epub 2016 May 20.

35.

Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.

Allen PJ, Kuk D, Castillo CF, Basturk O, Wolfgang CL, Cameron JL, Lillemoe KD, Ferrone CR, Morales-Oyarvide V, He J, Weiss MJ, Hruban RH, Gönen M, Klimstra DS, Mino-Kenudson M.

Ann Surg. 2017 Jan;265(1):185-191. doi: 10.1097/SLA.0000000000001763.

36.

Mismatch Repair Protein Expression in Clear Cell Carcinoma of the Ovary: Incidence and Morphologic Associations in 109 Cases.

Bennett JA, Morales-Oyarvide V, Campbell S, Longacre TA, Oliva E.

Am J Surg Pathol. 2016 May;40(5):656-63. doi: 10.1097/PAS.0000000000000602.

PMID:
26813747
37.

Preoperative biliary drainage does not increase major complications in pancreaticoduodenectomy: a large single center experience from the Massachusetts General Hospital.

Sahora K, Morales-Oyarvide V, Ferrone C, Fong ZV, Warshaw AL, Lillemoe KD, Fernández-del Castillo C.

J Hepatobiliary Pancreat Sci. 2016 Mar;23(3):181-7. doi: 10.1002/jhbp.322. Epub 2016 Feb 23.

PMID:
26768943
38.

Tumor islands and spread through air spaces: Distinct patterns of invasion in lung adenocarcinoma.

Morales-Oyarvide V, Mino-Kenudson M.

Pathol Int. 2016 Jan;66(1):1-7. doi: 10.1111/pin.12368. Epub 2015 Dec 8. Review.

PMID:
26642845
39.

Cost-effectiveness analysis of EGFR mutation testing in patients with non-small cell lung cancer (NSCLC) with gefitinib or carboplatin-paclitaxel.

Arrieta O, Anaya P, Morales-Oyarvide V, Ramírez-Tirado LA, Polanco AC.

Eur J Health Econ. 2016 Sep;17(7):855-63. doi: 10.1007/s10198-015-0726-5. Epub 2015 Sep 4.

PMID:
26338546
40.

Diagnosis of EML4-ALK Translocation With FISH, Immunohistochemistry, and Real-time Polymerase Chain Reaction in Patients With Non-Small Cell Lung Cancer.

Cruz-Rico G, Avilés-Salas A, Segura-González M, Espinosa-García AM, Ramírez-Tirado LA, Morales-Oyarvide V, Rojas-Marín C, Cardona AF, Arrieta O.

Am J Clin Oncol. 2017 Dec;40(6):631-638. doi: 10.1097/COC.0000000000000213.

PMID:
26270443
41.

Acute pancreatitis in intraductal papillary mucinous neoplasms: A common predictor of malignant intestinal subtype.

Morales-Oyarvide V, Mino-Kenudson M, Ferrone CR, Gonzalez-Gonzalez LA, Warshaw AL, Lillemoe KD, Fernández-del Castillo C.

Surgery. 2015 Nov;158(5):1219-25. doi: 10.1016/j.surg.2015.04.029. Epub 2015 Jun 13.

PMID:
26077509
42.

Effects of Comorbidities on Outcomes of Patients With Intraductal Papillary Mucinous Neoplasms.

Sahora K, Ferrone CR, Brugge WR, Morales-Oyarvide V, Warshaw AL, Lillemoe KD, Fernández-del Castillo C.

Clin Gastroenterol Hepatol. 2015 Oct;13(10):1816-23. doi: 10.1016/j.cgh.2015.04.177. Epub 2015 May 6.

PMID:
25956837
43.

Patterns of Recurrence After Resection of IPMN: Who, When, and How?

Marchegiani G, Mino-Kenudson M, Ferrone CR, Morales-Oyarvide V, Warshaw AL, Lillemoe KD, Castillo CF.

Ann Surg. 2015 Dec;262(6):1108-14. doi: 10.1097/SLA.0000000000001008.

PMID:
25793719
44.

Medical care costs incurred by patients with smoking-related non-small cell lung cancer treated at the National Cancer Institute of Mexico.

Arrieta O, Quintana-Carrillo RH, Ahumada-Curiel G, Corona-Cruz JF, Correa-Acevedo E, Zinser-Sierra J, de la Mata-Moya D, Mohar-Betancourt A, Morales-Oyarvide V, Reynales-Shigematsu LM.

Tob Induc Dis. 2015 Feb 4;12(1):25. doi: 10.1186/s12971-014-0025-4. eCollection 2014.

45.

Characterization of epithelial subtypes of intraductal papillary mucinous neoplasm of the pancreas with endoscopic ultrasound and cyst fluid analysis.

Yoon WJ, Daglilar ES, Mino-Kenudson M, Morales-Oyarvide V, Pitman MB, Brugge WR.

Endoscopy. 2014 Dec;46(12):1071-7. doi: 10.1055/s-0034-1377629. Epub 2014 Sep 10.

PMID:
25208034
46.

The effect of antecolic versus retrocolic reconstruction on delayed gastric emptying after classic non-pylorus-preserving pancreaticoduodenectomy.

Sahora K, Morales-Oyarvide V, Thayer SP, Ferrone CR, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C.

Am J Surg. 2015 Jun;209(6):1028-35. doi: 10.1016/j.amjsurg.2014.04.015. Epub 2014 Jul 1.

PMID:
25124295
47.

Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer.

Macedo-Pérez EO, Morales-Oyarvide V, Mendoza-García VO, Dorantes-Gallareta Y, Flores-Estrada D, Arrieta O.

Cancer Chemother Pharmacol. 2014 Oct;74(4):681-90. doi: 10.1007/s00280-014-2522-9. Epub 2014 Jul 25.

PMID:
25059320
48.

IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection.

Marchegiani G, Mino-Kenudson M, Sahora K, Morales-Oyarvide V, Thayer S, Ferrone C, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C.

Ann Surg. 2015 May;261(5):976-83. doi: 10.1097/SLA.0000000000000813.

49.

High-grade lung adenocarcinomas with micropapillary and/or solid patterns: a review.

Morales-Oyarvide V, Mino-Kenudson M.

Curr Opin Pulm Med. 2014 Jul;20(4):317-23. doi: 10.1097/MCP.0000000000000070. Review.

PMID:
24852329
50.

Cystic pancreatic neuroendocrine tumors: the value of cytology in preoperative diagnosis.

Morales-Oyarvide V, Yoon WJ, Ingkakul T, Forcione DG, Casey BW, Brugge WR, Fernández-del Castillo C, Pitman MB.

Cancer Cytopathol. 2014 Jun;122(6):435-44. doi: 10.1002/cncy.21403. Epub 2014 Mar 3.

Supplemental Content

Loading ...
Support Center